Lupin is one of the largest pharmaceutical company in India and a dominant player in respiratory arena.

With a presence in over 100 countries, Lupin offers high-quality yet affordable medicines for most of the chronic diseases addressing unmet needs in many parts of the world.

Lupin’s world class manufacturing facilities are spread across India, USA, Mexico and Brazil. These 15 facilities benchmarked to international standards are set up to meet stringent quality standards and approved by international regulatory agencies like US FDA, UK MHRA, TGA Australia, WHO, and the MCC South Africa.

Lupin has specialized portfolio in respiratory domain:

Asthma & COPD

Allergic Rhinitis

Pulmonary Hypertension

Idiopathic Pulmonary Fibrosis

Pediatric nebulization

Oral Vaccines

Nebulized Antibiotics

Devices for Asthma & COPD

Lupin has always been in the forefront with unique scientific initiatives to support HCPs & budding pulmonologists.